Literature DB >> 7640588

Exacerbation of idiopathic Parkinson's disease by naproxen.

S Shaunak1, P Brown, J A Morgan-Hughes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7640588      PMCID: PMC2550492          DOI: 10.1136/bmj.311.7002.422b

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Acute parkinsonism associated with flurbibrofen.

Authors:  T P Enevoldson; C M Wiles; G V Sawle
Journal:  BMJ       Date:  1990-02-24

2.  Acute exacerbation of Parkinson's disease with sulindac.

Authors:  R Sandyk; M A Gillman
Journal:  Ann Neurol       Date:  1985-01       Impact factor: 10.422

3.  Extrapyramidal reactions to anti-inflammatory drugs.

Authors:  N Wood; H S Pall; A C Williams; C Dieppe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

4.  Diflunisal in idiopathic Parkinson's disease.

Authors:  C B Anderson; E J Larson
Journal:  Neurology       Date:  1984-03       Impact factor: 9.910

5.  Extrapyramidal symptoms following mefenamic acid.

Authors:  A Cremona-Barbaro
Journal:  J R Soc Med       Date:  1983-05       Impact factor: 18.000

  5 in total
  3 in total

Review 1.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

Review 2.  M1 and M2 immune activation in Parkinson's Disease: Foe and ally?

Authors:  M S Moehle; A B West
Journal:  Neuroscience       Date:  2014-11-25       Impact factor: 3.590

Review 3.  Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.

Authors:  Sudhakar R Subramaniam; Howard J Federoff
Journal:  Front Aging Neurosci       Date:  2017-06-08       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.